Hui et al. demonstrated that the Pin inhibitor API-1 enhances BRAF inhibitor sensitivity in BRAF-mutant thyroid cancer by reducing HER3-mediated feedback activation of MAPK/ERK and PI3K/AKT pathways [83]. The gene discussed is AKT1; the disease is thyroid gland carcinoma.